Cystic Fibrosis Diagnostic Tests Market – Global Industry Analysis, Growth, Segmentation and Forecast (2023-2029)

Cystic Fibrosis Diagnostic Tests Market is expected to grow at a CAGR of 4% during the forecast period. Global Cystic Fibrosis Diagnostic Tests Market is expected to reach US$ 6.40 Bn. by 2029.

Cystic Fibrosis Diagnostic Tests Market Introduction and Overview

Cystic Fibrosis is an inherited disease, which causes severe damage to the lungs, digestive system, and other organs in the body. It is an autosomal recessive, monogenetic disorder caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. These mutations lead to alterations in protein, causing thick mucus to build up in the lungs and other organs. This causes difficulty in breathing and accumulation of mucus. Germs can thrive on the accumulated mucus causing infection, inflammation and severe respiratory damage. The increased prevalence of Cystic Fibrosis has led to an increase in the test market. Currently, available tests are new-born screening, Chest X-ray, sweat test, lung functions test, and genetic testing. FDA approval for Trikafta (elexacaftor/ivacaftor/tezacaftor) drug in 2022 boosted the CF tests market by over $1 Bn. The total sales were driven up by 29% to $1.6 Bn.Cystic Fibrosis Diagnostic Tests MarketTo know about the Research Methodology :- Request Free Sample Report Gene Therapy could offer a comprehensive cure for cystic fibrosis- Innovations in delivering genetic sequences and gene replacement therapies are helping the market to gain momentum. In addition to this, funding’s from non-profit organizations for research and partnerships of top players for developing advanced gene therapies are aiding the market growth at a fast rate. Companies are scouting for new tools and technologies and in the process to boost their product pipelines which in turn will help the market grow. The report covers the detailed analysis of global Cystic Fibrosis Diagnostic Tests market with the classifications of the market based on test type, End-users, and region. Analysis of past market dynamics from 2018 to 2022 is given in the report, which will help readers to benchmark the past trends with current market scenarios with the key players contribution in it. The report has profiled twenty four key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analysing the market and estimation the size of the same. The growing healthcare infrastructure in each region is different and focus is given on availability of advanced technology and new techniques. Report has come up with recommendations for future hot spot in APAC region. New research findings, funding policies for projects and its impact on CF Diagnostic Tests market are covered ion the report.

Cystic Fibrosis Diagnostic Tests Market Segment Analysis

The market for Test Type is expected to grow at a CAGR of xx% during the forecast period. The need for diagnosis of the condition at the primary stage is important. The increase in the prevalence of this condition will lead to a rise in the number of tests performed, thereby driving the market growth.

Cystic Fibrosis Diagnostic Tests Market Regional Analysis

North America is expected to contribute a dominant share in the market due to an increase in awareness about Cystic Fibrosis, low test costs, and highly developed infrastructure followed by Europe by 2029. Whereas in the APAC region, the market is likely to grow at a CAGR of xx% during the forecast period. Increasing cases of patients with inflammatory bowel diseases and developing healthcare infrastructure are elevating the market. The objective of the report is to present a comprehensive analysis of the global market of all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analysed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding global market dynamics, structure by analysing the market segments and project the global market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in global market make the report investor’s guide.

Cystic Fibrosis Diagnostic Tests Market Scope: Inquire before buying

Cystic Fibrosis Diagnostic Tests Market
Report Coverage Details
Base Year: 2022 Forecast Period: 2023-2029
Historical Data: 2018 to 2022 Market Size in 2022: US $ 4.86 Bn.
Forecast Period 2023 to 2029 CAGR: 4% Market Size in 2029: US $ 6.40 Bn.
Segments Covered: by Type Genetic Tests Faecal Test Immunoreactive Trypsinogen (IRT) Test Sweat Chloride Tests Pulmonary function Tests
by End-user Hospitals Diagnostics Laboratories Others

Cystic Fibrosis Diagnostic Tests Market, by Region

North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)

Cystic Fibrosis Diagnostic Tests Market Key Players:

1. Quidel Corporation 2. Quest Diagnostics 3. Vertex Pharmaceuticals 4. Verona Pharma 5. Abbott Laboratories 6. Pfizer Inc 7. Novartis 8. Creative Diagnostics 9. Invitae Corporation 10. Asper Biogene 11. GeneDx 12. Illumina Inc 13. Elucigene Diagnostics 14. BillionToOne Inc 15. ELITech Group 16. NovaBiotics Ltd 17. Cystic Fibrosis Foundation Therapeutics, Inc 18. Galapagos NV 19. AbbVie 20. Gilead Sciences 21. F.Hoffman La Roche 22. Forest Laboratories 23. Genentech 24. Pharmaxis Frequently Asked Questions: 1. Which region has the largest share in Global Cystic Fibrosis Diagnostic Tests Market? Ans: North America region held the highest share in 2022. 2. What is the growth rate of Global Cystic Fibrosis Diagnostic Tests Market? Ans: The Global Cystic Fibrosis Diagnostic Tests Market is growing at a CAGR of 4% during forecasting period 2023-2029. 3. What is scope of the Global Cystic Fibrosis Diagnostic Tests Market report? Ans: Global market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Cystic Fibrosis Diagnostic Tests Market? Ans: The important key players in the Global Cystic Fibrosis Diagnostic Tests Market are – Quidel Corporation, Quest Diagnostics, Vertex Pharmaceuticals, Verona Pharma, Abbott Laboratories, Pfizer Inc, Novartis, Creative Diagnostics, Invitae Corporation, Asper Biogene, 5. What is the study period of this Market? Ans: The Global Cystic Fibrosis Diagnostic Tests Market is studied from 2022 to 2029.
Global Cystic Fibrosis Diagnostic Tests Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Size, By Market Value (US$ Mn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Analysis and Forecast 6.1. CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Analysis and Forecast, By Test Type 7.1. Introduction and Definition 7.2. Key Findings 7.3. CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Value Share Analysis, By Test Type 7.4. CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Size (US$ Mn) Forecast, By Test Type 7.5. CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Analysis, By Test Type 7.6. CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Attractiveness Analysis, By Test Type 8. Global CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Analysis and Forecast, By End-user 8.1. Introduction and Definition 8.2. Key Findings 8.3. CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Value Share Analysis, By End-user 8.4. CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Size (US$ Mn) Forecast, By End-user 8.5. CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Analysis, By End-user 8.6. CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Attractiveness Analysis, By End-user 9. Global CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Analysis, By Region 9.1. CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Value Share Analysis, By Region 9.2. CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Size (US$ Mn) Forecast, By Region 9.3. CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Attractiveness Analysis, By Region 10. North America CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Analysis 10.1. Key Findings 10.2. North America CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Overview 10.3. North America CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Value Share Analysis, By Test Type 10.4. North America CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type 10.4.1. Genetic Tests 10.4.2. Faecal Test 10.4.3. Immunoreactive Trypsinogen (IRT) Test 10.4.4. Sweat Chloride Tests 10.4.5. Pulmonary function Tests 10.5. North America CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Value Share Analysis, By End-user 10.6. North America CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user 10.6.1. Hospitals 10.6.2. Diagnostics 10.6.3. Laboratories 10.6.4. Others 10.7. North America CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Value Share Analysis, By Country 10.8. North America CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Country 10.8.1. U.S. 10.8.2. Canada 10.8.3. Mexico 10.9. North America CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Analysis, By Country 10.10. U.S. CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type 10.10.1. Genetic Tests 10.10.2. Faecal Test 10.10.3. Immunoreactive Trypsinogen (IRT) Test 10.10.4. Sweat Chloride Tests 10.10.5. Pulmonary function Tests 10.11. U.S. CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user 10.11.1. Hospitals 10.11.2. Diagnostics 10.11.3. Laboratories 10.11.4. Others 10.12. Canada CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type 10.12.1. Genetic Tests 10.12.2. Faecal Test 10.12.3. Immunoreactive Trypsinogen (IRT) Test 10.12.4. Sweat Chloride Tests 10.12.5. Pulmonary function Tests 10.13. Canada CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user 10.13.1. Hospitals 10.13.2. Diagnostics 10.13.3. Laboratories 10.13.4. Others 10.14. Mexico CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type 10.14.1. Genetic Tests 10.14.2. Faecal Test 10.14.3. Immunoreactive Trypsinogen (IRT) Test 10.14.4. Sweat Chloride Tests 10.14.5. Pulmonary function Tests 10.15. Mexico CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user 10.15.1. Hospitals 10.15.2. Diagnostics 10.15.3. Laboratories 10.15.4. Others 10.16. North America CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Attractiveness Analysis 10.16.1. By Test Type 10.16.2. By End-user 10.17. PEST Analysis 10.18. Key Trends 10.19. Key Developments 11. Europe CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Analysis 11.1. Key Findings 11.2. Europe CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Overview 11.3. Europe CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Value Share Analysis, By Test Type 11.4. Europe CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type 11.4.1. Genetic Tests 11.4.2. Faecal Test 11.4.3. Immunoreactive Trypsinogen (IRT) Test 11.4.4. Sweat Chloride Tests 11.4.5. Pulmonary function Tests 11.5. Europe CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Value Share Analysis, By End-user 11.6. Europe CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user 11.6.1. Hospitals 11.6.2. Diagnostics 11.6.3. Laboratories 11.6.4. Others 11.7. Europe CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Value Share Analysis, By Country 11.8. Europe CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Country 11.8.1. Germany 11.8.2. U.K. 11.8.3. France 11.8.4. Italy 11.8.5. Spain 11.8.6. Sweden 11.8.7. CIS countries 11.8.8. Rest of Europe 11.9. Germany CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type 11.9.1. Genetic Tests 11.9.2. Faecal Test 11.9.3. Immunoreactive Trypsinogen (IRT) Test 11.9.4. Sweat Chloride Tests 11.9.5. Pulmonary function Tests 11.10. Germany CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user 11.10.1. Hospitals 11.10.2. Diagnostics 11.10.3. Laboratories 11.10.4. Others 11.11. U.K. CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type 11.11.1. Genetic Tests 11.11.2. Faecal Test 11.11.3. Immunoreactive Trypsinogen (IRT) Test 11.11.4. Sweat Chloride Tests 11.11.5. Pulmonary function Tests 11.12. U.K. CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user 11.12.1. Hospitals 11.12.2. Diagnostics 11.12.3. Laboratories 11.12.4. Others 11.13. France CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type 11.13.1. Genetic Tests 11.13.2. Faecal Test 11.13.3. Immunoreactive Trypsinogen (IRT) Test 11.13.4. Sweat Chloride Tests 11.13.5. Pulmonary function Tests 11.14. France CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user 11.14.1. Hospitals 11.14.2. Diagnostics 11.14.3. Laboratories 11.14.4. Others 11.15. Italy CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type 11.15.1. Genetic Tests 11.15.2. Faecal Test 11.15.3. Immunoreactive Trypsinogen (IRT) Test 11.15.4. Sweat Chloride Tests 11.15.5. Pulmonary function Tests 11.16. Italy CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user 11.16.1. Hospitals 11.16.2. Diagnostics 11.16.3. Laboratories 11.16.4. Others 11.17. Spain CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type 11.17.1. Genetic Tests 11.17.2. Faecal Test 11.17.3. Immunoreactive Trypsinogen (IRT) Test 11.17.4. Sweat Chloride Tests 11.17.5. Pulmonary function Tests 11.18. Spain CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user 11.18.1. Hospitals 11.18.2. Diagnostics 11.18.3. Laboratories 11.18.4. Others 11.19. Sweden CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type 11.19.1. Genetic Tests 11.19.2. Faecal Test 11.19.3. Immunoreactive Trypsinogen (IRT) Test 11.19.4. Sweat Chloride Tests 11.19.5. Pulmonary function Tests 11.20. Sweden CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user 11.20.1. Hospitals 11.20.2. Diagnostics 11.20.3. Laboratories 11.20.4. Others 11.21. CIS countries CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type 11.21.1. Genetic Tests 11.21.2. Faecal Test 11.21.3. Immunoreactive Trypsinogen (IRT) Test 11.21.4. Sweat Chloride Tests 11.21.5. Pulmonary function Tests 11.22. CIS countries CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user 11.22.1. Hospitals 11.22.2. Diagnostics 11.22.3. Laboratories 11.22.4. Others 11.23. Rest of Europe CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type 11.23.1. Genetic Tests 11.23.2. Faecal Test 11.23.3. Immunoreactive Trypsinogen (IRT) Test 11.23.4. Sweat Chloride Tests 11.23.5. Pulmonary function Tests 11.24. Rest of Europe CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user 11.24.1. Hospitals 11.24.2. Diagnostics 11.24.3. Laboratories 11.24.4. Others 11.25. Europe CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Attractiveness Analysis 11.25.1. By End-user 11.25.2. By Test Type 11.26. PEST Analysis 11.27. Key Trends 11.28. Key Developments 12. Asia Pacific CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Analysis 12.1. Key Findings 12.2. Asia Pacific CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Overview 12.3. Asia Pacific CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Value Share Analysis, By Test Type 12.4. Asia Pacific CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type 12.4.1. Genetic Tests 12.4.2. Faecal Test 12.4.3. Immunoreactive Trypsinogen (IRT) Test 12.4.4. Sweat Chloride Tests 12.4.5. Pulmonary function Tests 12.5. Asia Pacific CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Value Share Analysis, By End-user 12.6. Asia Pacific CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user 12.6.1. Hospitals 12.6.2. Diagnostics 12.6.3. Laboratories 12.6.4. Others 12.7. Asia Pacific CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Value Share Analysis, By Country 12.8. Asia Pacific CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Country 12.8.1. China 12.8.2. India 12.8.3. Japan 12.8.4. South Korea 12.8.5. Australia 12.8.6. ASEAN 12.8.7. Rest of Asia Pacific 12.9. Asia Pacific CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Analysis, By Country 12.10. China CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type 12.10.1. Genetic Tests 12.10.2. Faecal Test 12.10.3. Immunoreactive Trypsinogen (IRT) Test 12.10.4. Sweat Chloride Tests 12.10.5. Pulmonary function Tests 12.11. China CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user 12.11.1. Hospitals 12.11.2. Diagnostics 12.11.3. Laboratories 12.11.4. Others 12.12. India CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type 12.12.1. Genetic Tests 12.12.2. Faecal Test 12.12.3. Immunoreactive Trypsinogen (IRT) Test 12.12.4. Sweat Chloride Tests 12.12.5. Pulmonary function Tests 12.13. India CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user 12.13.1. Hospitals 12.13.2. Diagnostics 12.13.3. Laboratories 12.13.4. Others 12.14. Japan CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type 12.14.1. Genetic Tests 12.14.2. Faecal Test 12.14.3. Immunoreactive Trypsinogen (IRT) Test 12.14.4. Sweat Chloride Tests 12.14.5. Pulmonary function Tests 12.15. Japan CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user 12.15.1. Hospitals 12.15.2. Diagnostics 12.15.3. Laboratories 12.15.4. Others 12.16. South Korea CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type 12.16.1. Genetic Tests 12.16.2. Faecal Test 12.16.3. Immunoreactive Trypsinogen (IRT) Test 12.16.4. Sweat Chloride Tests 12.16.5. Pulmonary function Tests 12.17. South Korea CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user 12.17.1. Hospitals 12.17.2. Diagnostics 12.17.3. Laboratories 12.17.4. Others 12.18. Australia CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type 12.18.1. Genetic Tests 12.18.2. Faecal Test 12.18.3. Immunoreactive Trypsinogen (IRT) Test 12.18.4. Sweat Chloride Tests 12.18.5. Pulmonary function Tests 12.19. Australia CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user 12.19.1. Hospitals 12.19.2. Diagnostics 12.19.3. Laboratories 12.19.4. Others 12.20. ASEAN CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type 12.20.1. Genetic Tests 12.20.2. Faecal Test 12.20.3. Immunoreactive Trypsinogen (IRT) Test 12.20.4. Sweat Chloride Tests 12.20.5. Pulmonary function Tests 12.21. ASEAN CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user 12.21.1. Hospitals 12.21.2. Diagnostics 12.21.3. Laboratories 12.21.4. Others 12.22. Rest of Asia Pacific CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type 12.22.1. Genetic Tests 12.22.2. Faecal Test 12.22.3. Immunoreactive Trypsinogen (IRT) Test 12.22.4. Sweat Chloride Tests 12.22.5. Pulmonary function Tests 12.23. Rest of Asia Pacific CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user 12.23.1. Hospitals 12.23.2. Diagnostics 12.23.3. Laboratories 12.23.4. Others 12.24. Asia Pacific CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Attractiveness Analysis 12.24.1. By Test Type 12.24.2. By End-user 12.25. PEST Analysis 12.26. Key Trends 12.27. Key Developments 13. Middle East & Africa CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Analysis 13.1. Key Findings 13.2. Middle East & Africa CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Overview 13.3. Middle East & Africa CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Value Share Analysis, By Test Type 13.4. Middle East & Africa CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type 13.4.1. Genetic Tests 13.4.2. Faecal Test 13.4.3. Immunoreactive Trypsinogen (IRT) Test 13.4.4. Sweat Chloride Tests 13.4.5. Pulmonary function Tests 13.5. Middle East & Africa CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Value Share Analysis, By End-user 13.6. Middle East & Africa CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user 13.6.1. Hospitals 13.6.2. Diagnostics 13.6.3. Laboratories 13.6.4. Others 13.7. Middle East & Africa CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Value Share Analysis, By Country 13.8. Middle East & Africa CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Country 13.8.1. GCC Countries 13.8.2. South Africa 13.8.3. Nigeria 13.8.4. Egypt 13.8.5. Rest of Middle East & Africa 13.9. Middle East & Africa CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Analysis, By Country 13.10. GCC Countries CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type 13.10.1. Genetic Tests 13.10.2. Faecal Test 13.10.3. Immunoreactive Trypsinogen (IRT) Test 13.10.4. Sweat Chloride Tests 13.10.5. Pulmonary function Tests 13.11. GCC Countries CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user 13.11.1. Hospitals 13.11.2. Diagnostics 13.11.3. Laboratories 13.11.4. Others 13.12. South Africa CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type 13.12.1. Genetic Tests 13.12.2. Faecal Test 13.12.3. Immunoreactive Trypsinogen (IRT) Test 13.12.4. Sweat Chloride Tests 13.12.5. Pulmonary function Tests 13.13. South Africa CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user 13.13.1. Hospitals 13.13.2. Diagnostics 13.13.3. Laboratories 13.13.4. Others 13.14. Nigeria CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type 13.14.1. Genetic Tests 13.14.2. Faecal Test 13.14.3. Immunoreactive Trypsinogen (IRT) Test 13.14.4. Sweat Chloride Tests 13.14.5. Pulmonary function Tests 13.15. Nigeria CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user 13.15.1. Hospitals 13.15.2. Diagnostics 13.15.3. Laboratories 13.15.4. Others 13.16. Egypt CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type 13.16.1. Genetic Tests 13.16.2. Faecal Test 13.16.3. Immunoreactive Trypsinogen (IRT) Test 13.16.4. Sweat Chloride Tests 13.16.5. Pulmonary function Tests 13.17. Egypt CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user 13.17.1. Hospitals 13.17.2. Diagnostics 13.17.3. Laboratories 13.17.4. Others 13.18. Rest of Middle East & Africa CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type 13.18.1. Genetic Tests 13.18.2. Faecal Test 13.18.3. Immunoreactive Trypsinogen (IRT) Test 13.18.4. Sweat Chloride Tests 13.18.5. Pulmonary function Tests 13.19. Rest of Middle East & Africa CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user 13.19.1. Hospitals 13.19.2. Diagnostics 13.19.3. Laboratories 13.19.4. Others 13.20. Middle East & Africa CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Attractiveness Analysis 13.20.1. By Test Type 13.20.2. By End-user 13.21. PEST Analysis 13.22. Key Trends 13.23. Key Developments 14. South America CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Analysis 14.1. Key Findings 14.2. South America CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Overview 14.3. South America CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Value Share Analysis, By Test Type 14.4. South America CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type 14.4.1. Genetic Tests 14.4.2. Faecal Test 14.4.3. Immunoreactive Trypsinogen (IRT) Test 14.4.4. Sweat Chloride Tests 14.4.5. Pulmonary function Tests 14.5. South America CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Value Share Analysis, By End-user 14.6. South America CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user 14.6.1. Hospitals 14.6.2. Diagnostics 14.6.3. Laboratories 14.6.4. Others 14.7. South America CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Value Share Analysis, By Country 14.8. South America CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Country 14.8.1. Brazil 14.8.2. Colombia 14.8.3. Argentina 14.8.4. Rest of South America 14.9. South America CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Analysis, By Country 14.10. Brazil CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type 14.10.1. Genetic Tests 14.10.2. Faecal Test 14.10.3. Immunoreactive Trypsinogen (IRT) Test 14.10.4. Sweat Chloride Tests 14.10.5. Pulmonary function Tests 14.11. Brazil CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user 14.11.1. Hospitals 14.11.2. Diagnostics 14.11.3. Laboratories 14.11.4. Others 14.12. Colombia CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type 14.12.1. Genetic Tests 14.12.2. Faecal Test 14.12.3. Immunoreactive Trypsinogen (IRT) Test 14.12.4. Sweat Chloride Tests 14.12.5. Pulmonary function Tests 14.13. Colombia CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user 14.13.1. Hospitals 14.13.2. Diagnostics 14.13.3. Laboratories 14.13.4. Others 14.14. Argentina CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type 14.14.1. Genetic Tests 14.14.2. Faecal Test 14.14.3. Immunoreactive Trypsinogen (IRT) Test 14.14.4. Sweat Chloride Tests 14.14.5. Pulmonary function Tests 14.15. Argentina CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user 14.15.1. Hospitals 14.15.2. Diagnostics 14.15.3. Laboratories 14.15.4. Others 14.16. Rest of South America CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By Test Type 14.16.1. Genetic Tests 14.16.2. Faecal Test 14.16.3. Immunoreactive Trypsinogen (IRT) Test 14.16.4. Sweat Chloride Tests 14.16.5. Pulmonary function Tests 14.17. Rest of South America CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Forecast, By End-user 14.17.1. Hospitals 14.17.2. Diagnostics 14.17.3. Laboratories 14.17.4. Others 14.18. South America CYSTIC FIBROSIS DIAGNOSTIC TESTS Market Attractiveness Analysis 14.18.1. By Test Type 14.18.2. By End-user 14.19. PEST Analysis 14.20. Key Trends 14.21. Key Developments 15. Company Profiles 15.1. Market Share Analysis, By Company 15.2. Competition Matrix 15.2.1. Competitive Benchmarking of key players By price, presence, market share, End-user, and R&D investment 15.2.2. New Product Launches and Product Enhancements 15.2.3. Market Consolidation 15.2.3.1. M&A By Regions, Investment and End-user 15.2.3.2. M&A Key Players, Forward Integration and Backward Integration 15.3. Company Profiles: Key Players 15.3.1. Quidel Corporation 15.3.1.1. Company Overview 15.3.1.2. Financial Overview 15.3.1.3. Product Portfolio 15.3.1.4. Business Strategy 15.3.1.5. Recent Developments 15.3.1.6. Development Footprint 15.3.2. Quest Diagnostics 15.3.3. Vertex Pharmaceuticals 15.3.4. Verona Pharma 15.3.5. Abbott Laboratories 15.3.6. Pfizer Inc 15.3.7. Novartis 15.3.8. Creative Diagnostics 15.3.9. Invitae Corporation 15.3.10. Asper Biogene 15.3.11. GeneDx 15.3.12. Illumina Inc 15.3.13. Elucigene Diagnostics 15.3.14. BillionToOne Inc 15.3.15. ELITech Group 15.3.16. NovaBiotics Ltd 15.3.17. Cystic Fibrosis Foundation Therapeutics, Inc 15.3.18. Galapagos NV 15.3.19. AbbVie 15.3.20. Gilead Sciences 15.3.21. F.Hoffman La Roche 15.3.22. Forest Laboratories 15.3.23. Genentech 15.3.24. Pharmaxis

About This Report

Report ID 81835
Category Healthcare
Published Date July 2023
Updated Date
  • INQUIRE BEFORE BUYING